Navigation Links
Fat Kills Cancer: Turning Stem Cells from Fat Tissue into,Personalized, Cancer-Targeted Therapeutics

PHILADELPHIA, July 3, 2007 ? Researchers in Slovakia have been able to derive mesenchymal stem cells from human adipose, or fat, tissue and engineer them into “suicide genes” that seek out and destroy tumors like tiny homing missiles. This gene therapy approach is a novel way to attack small tumor metastases that evade current detection techniques and treatments, the researchers conclude in the July 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

“These fat-derived stem cells could be exploited for personalized cell-based therapeutics,” said the study’s lead investigator, Cestmir Altaner, Ph.D., D.Sc., an associate professor in the Cancer Research Institute of the Slovak Academy of Sciences in Bratislava. “Nearly everyone has some fat tissue they can spare, and this tissue could be a source of cells for cancer treatment that can be adapted into specific vehicles for drug transport.”

Mesenchymal stem cells help repair damaged tissue and organs by renewing injured cells. They are also found in the mass of normal cells that mix with cancer cells to make up a solid tumor. Researchers believe mesenchymal stem cells “see” a tumor as a damaged organ and migrate to it, and so might be utilized as a “vehicle” for treatment that can find both primary tumors and small metastases. These stem cells also have some plasticity, which means they can be converted by the micro environment of a given tissue into specialized cells, Altaner says.

After extracting the stem cells from human fat tissue the researchers worked to find a less toxic way to treat colon cancer than the standard-of-care chemotherapy agent, 5-fluorouracil (5-FU), which can produce toxic side effects in normal cells. They expanded the number of mesenchymal stem cells in the laboratory and then used a retrovirus vector to i
'"/>




Page: 1 2 3

Related medicine technology :

1. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
2. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
5. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
6. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
7. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
10. Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetixs AAGP
11. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
Post Your Comments:
(Date:5/16/2008)...May 16 /- Data from three studies,eva...emoglobin (Hb) levels,and the rate of blood transf...ions on reimbursement for erythropoiesis-stimulati...n,s blood supply, will be presented at the,America...ng later this,month. The meeting will take place i...
(Date:5/16/2008)...16 /- Veridex, LLC announced today th...ion of America Holdings,(LabCorp), has commerciall...e cancer. The new assay uses the biological specif...ecting the methylation of the gene,GST-Pi. Methyla...y in,cancer. Veridex is developing the methylation...
(Date:5/15/2008)... May 15 /- Patients with breast or,co...ncers, can expect,further treatment advances with ...umab) following new data that is being presented a...ASCO) annual meeting in Chicago at,the end of May....ting which,is the premier event for cancer therapy...
(Date:5/15/2008)...a, May 15 /- Cytopia Limite... its upcoming oral,presentation on CYT997 at the 2...ical Oncology (ASCO) will be accessible to the pub...m 9pm on Thursday 15 May (US EDT)., The oral pres...a novel,cytotoxic and vascular disrupting agent, i...
Breaking Medicine Technology:New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6UCLA to lead local study center in landmark government study of child health 2933 1UCLA to lead local study center in landmark government study of child health 2933 2UCLA to lead local study center in landmark government study of child health 2933 3UCLA to lead local study center in landmark government study of child health 2933 4NAMI Statement on U S Senator Pete Domenici Retirement 2930 1Biomoda and Averion International Announce Agreement for Clinical Services 2926 1Biomoda and Averion International Announce Agreement for Clinical Services 2926 2Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 1Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 2Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 3Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 4Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 5Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 6
...RUSALEM--(BUSINESS WIRE)--Mar 7, 2007 - BioLineRx ...t company, reported,today pre-clinical data from t...ective in preventing deterioration of the myocardi...ucing left ventricle,dilatation and eventual heart...MD, Director of the Neufeld Cardiac Research,Insti...
...udy Shows 51% Reduction in Intestinal Adenomas Sug...ntion of Intestinal,Cancer, EL DORADO HILLS, Calif...ed today the results of a study on the effect of r...ancerous mice, published,in the January 9, 2007 on... Cancer conducted at the Department of Cancer Stud...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4
(Date:5/16/2008).../PRNewswire/ -- ExamForce announced today the,hiri...rnment Sales Manager.,Mongeon formerly headed up t...s where he oversaw government sales and marketing ...op security certifications in the IT,industry., M...y left (ISC)2,Americas to spend more time with his...
(Date:5/16/2008)...s:, - 2007 Comprehensive Income increased 42% to ....9 million, - 2007 Gross Margin of 76%, - Produc...% to $12.2 million from $2.4 million as of Dece...Newswire-FirstCall/ -- Huiheng,Medical, Inc. ("Hui..., a,China-based leader in the development, sales a...
(Date:5/16/2008)... insulin-free for at least a year or two, , ...lanted islet cells help people with type 1 diabete...d appear to provide longer-term improved metabolic...ulin again, researchers report. , Using continu...he University of Miami Miller School of Medicine f...
(Date:5/16/2008)...6 /PRNewswire-USNewswire/ -- Karin Weisburgh,seni...fit publisher of,Consumer Reports magazine, was na...ar at CU,s Yonkers headquarters today., Ms. Weisb...ndles up in,the winter and rides in shirt sleeves ...along Quaker Ridge in New Rochelle, down Mill Road...
Breaking Medicine News(10 mins):Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6Health News:Islet Cell Transplants Aid Type 1 Diabetics 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 3Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 2Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 3
...dren became sick and one death was reported after ... According to reports about 2,500 children in the ...patitis A vaccine on the 16 and 17 of June without...-old child suffered an unspecified infection and b...
...rols might help to lower your "bad" LDL cholestero...een shown to block cholesterol's absorption, lower...lly absorbed by the intestines. The study had 29 ...es had high cholesterol, and 14 also had type 2 di...
...scranial Magnetic Stimulation' (TMS) maybe the wa...e aggressive electro-shock therapy. Electro-Shock ... resort to treat severe depression for many decade... impair memory for weeks after therapy and require...
...epartment of Medicine at the University of British...reen routine in childhood can reduce the risk of d...as always been an important part of an overall sun...nd reduce the number of sunburns, especially for c...
Other Medicine News:Health News:Strong Magnetic Stimulation Can Help Treating Severe Depression 2Health News:Use Of Sunscreen In Childhood And Prevents Future Skin Cancer 2
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation.
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions.
Adson bipolar forceps, 12 cm, straight.
Bipolar foot activated forceps.
Medicine Products: